The Western blot analysis and subsequent quantification revealed that OCT4, along with CD44 and CD133, exhibited markedly higher expression levels in CRC cells subjected to treatments with CAF-CM and SDF-1 transfection compared with those of the control groups. Here, CD44 is linked to colorectal carcinoma.